Extended mechanical ventilation in critically ill patients is associated with a heightened risk of ocular surface disorders, particularly exposure keratopathy. This review synthesizes recent research and guidelines pertaining to the pathophysiology, risk factors, clinical manifestations, diagnostic approaches, and management strategies for ocular surface protection in the intensive care setting. Emphasis is placed on evidence-based interventions, emerging therapies, and practical insights for optimizing ocular outcomes in mechanically ventilated patients.
Ocular surface complications are a frequently overlooked consequence of prolonged mechanical ventilation in the intensive care unit (ICU). Sedation, impaired blinking, and incomplete eyelid closure predispose these patients to corneal injury, which can progress to sight-threatening conditions if unrecognized or inadequately managed. This review aims to provide an up-to-date synthesis of critical care strategies for ocular surface protection, integrating current research, clinical guidelines, and expert consensus to inform multidisciplinary teams in the ICU.
The incidence of exposure keratopathy among mechanically ventilated patients varies widely, reported between 20% and 60% depending on patient populations, sedation protocols, and preventive measures implemented. The burden is greatest among those requiring deep sedation, neuromuscular blockade, or prolonged ventilation. Complications range from mild punctate epithelial erosions to severe microbial keratitis, corneal ulceration, and even permanent vision loss. In the context of increasing ICU admissions worldwide, the relevance of ocular surface protection is magnified.
Mechanical ventilation, particularly in deeply sedated or paralyzed patients, leads to reduced blink reflex, lagophthalmos (incomplete eyelid closure), and diminished tear film integrity. Exposure of the corneal surface disrupts the epithelial barrier, promoting desiccation, inflammation, and increased susceptibility to infection. The lack of ocular surface lubrication and impaired mucin production further exacerbate corneal vulnerability. Secondary insults, such as direct trauma from oxygen masks or tapes, and contamination from hospital flora, compound the risk of ocular morbidity.
Major risk factors include prolonged sedation, use of neuromuscular blocking agents, advanced age, pre-existing ocular surface or eyelid abnormalities, high positive end-expiratory pressure (PEEP), and facial edema. Additional contributors are prone positioning, high ventilator settings, and the presence of critical illness neuropathies. The absence of routine eye care protocols and staff training further elevates the risk of preventable ocular injury.
Ocular surface complications in ventilated patients often manifest as lagophthalmos, conjunctival injection, punctate keratopathy, and corneal epithelial defects. If unaddressed, these may evolve into microbial keratitis, corneal ulceration, stromal thinning, and, ultimately, perforation. Clinical assessment is challenging due to patient unresponsiveness, necessitating routine eye examinations by trained staff and, when feasible, ophthalmology consultation.
Diagnosis is primarily clinical and relies on direct inspection of the eyes for lid closure, conjunctival appearance, and corneal clarity. Fluorescein staining can reveal epithelial defects and early keratopathy. Bedside slit lamp examination or portable ophthalmoscopy may be warranted in complex cases. Infections should be suspected in the presence of purulent discharge, corneal infiltrates, or rapidly progressive ulcers, prompting microbiological sampling and tailored therapy.
Prevention remains the cornerstone of management. Regular assessment of eyelid closure and ocular surface integrity is essential. First-line interventions include lubrication with preservative-free artificial tears or ointments, eyelid taping or patching, and ensuring a humidified environment. In high-risk patients, moisture chambers or polyethylene covers may be employed. Established keratopathy warrants escalation to topical antibiotics, strict aseptic technique, and, in refractory cases, ophthalmology referral. Early identification and intervention are critical to mitigate long-term sequelae.
Recent research highlights the efficacy of novel ocular surface dressings, such as self-retaining moisture chambers and hydrogel patches, in preventing desiccation and promoting corneal healing. Prophylactic use of antibiotic ointments in selected populations has demonstrated a reduction in infectious complications. Technological advances, including automated eyelid closure devices and tele-ophthalmology for remote assessment, are under investigation and may soon be integrated into ICU care protocols. There is growing interest in the use of preservative-free formulations to minimize iatrogenic toxicity.
Society guidelines, including those from the Royal College of Ophthalmologists and various critical care societies, advocate for standardized eye care protocols in the ICU. Key recommendations encompass regular eye assessments, documentation of lid closure, routine lubrication, protective measures for at-risk patients, and prompt referral for ophthalmologic evaluation when indicated. Education of critical care staff in ocular surface assessment and management is emphasized as a quality improvement priority.
Ocular surface protection is an essential, yet often underappreciated, aspect of care for patients receiving extended mechanical ventilation. A systematic approach—incorporating risk assessment, prevention, early detection, and evidence-based management—can significantly reduce the burden of ocular morbidity in the ICU. Ongoing research and adoption of novel preventive strategies hold promise for further improving outcomes. Multidisciplinary collaboration and adherence to clinical guidelines are vital to safeguard the vision and quality of life in this vulnerable population.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation